Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users.
From the Department of Neurology, University of California, San Francisco (M.O.B., E.G.B., N.S.S., J.C.H.); and Department of Neurology, San Francisco General Hospital, CA (N.S.S., J.C.H.). maxime.baud@ucsf.edu.
Maxime O
MO
Baud
From the Department of Neurology, University of California, San Francisco (M.O.B., E.G.B., N.S.S., J.C.H.); and Department of Neurology, San Francisco General Hospital, CA (N.S.S., J.C.H.).
Ethan G
EG
Brown
From the Department of Neurology, University of California, San Francisco (M.O.B., E.G.B., N.S.S., J.C.H.); and Department of Neurology, San Francisco General Hospital, CA (N.S.S., J.C.H.).
Neel S
NS
Singhal
From the Department of Neurology, University of California, San Francisco (M.O.B., E.G.B., N.S.S., J.C.H.); and Department of Neurology, San Francisco General Hospital, CA (N.S.S., J.C.H.).
J Claude
JC
Hemphill
D000368:Aged; D002543:Cerebral Hemorrhage / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D019970:Cocaine-Related Disorders / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D010959:Tissue Plasminogen Activator
cocaine; stroke; thrombolytic therapy